Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FATE THERAPEUTICS INCFATE · Entity 5968 | Director | June 12, 2026 | June 15, 2026 |
| ILLUMINA, INC.ILMN · Entity 3137 | Director | May 21, 2025 | May 23, 2025 |
| VERACYTE, INC.VCYT · Entity 2018 | Director | June 11, 2026 | June 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FATE THERAPEUTICS INC
Report date June 12, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.06 · Expires 2036-06-12 | Direct | 87,900 |
Reported balance
After 2026-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 87,900 · Balance 87,900 F1: This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. F2: The shares subject to this option shall vest and become exercisable on the earlier of (i) June 12, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's Annual Meeting of Stockholders.
F2: The shares subject to this option shall vest and become exercisable on the earlier of (i) June 12, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
ILLUMINA, INC.
Report date May 21, 2025 · Filed May 23, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,139 |
Reported balance
After 2025-05-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-05-21 · Grant · Acquired 3,780 · Balance 22,139 F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. F2: In connection with Illumina's spin out of Grail, Inc., which was completed on June 24, 2024, all unvested equity award units were adjusted pursuant to Illumina's Amended and Restated 2015 Stock and Incentive Plan. Dr. Epstein's unvested RSUs were increased by 53 units as a result of such adjustment. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.
F2: In connection with Illumina's spin out of Grail, Inc., which was completed on June 24, 2024, all unvested equity award units were adjusted pursuant to Illumina's Amended and Restated 2015 Stock and Incentive Plan. Dr. Epstein's unvested RSUs were increased by 53 units as a result of such adjustment.
VERACYTE, INC.
Report date June 11, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 57,718 |
Reported balance
After 2026-06-11 transaction · row 1
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 5,272 · Balance 57,718 F1: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2019 Filed May 3, 2019 21:18 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 2,228 | $310.29 | $691,329.24 |
DisclosureSEC source: 0001127602-19-017302 · form4.xml · nonDerivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,828 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 2,228 shares sold ranging from $309.94 to $310.9025 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2019 Filed May 3, 2019 21:18 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,200 | $309.51 | $371,414.04 |
DisclosureSEC source: 0001127602-19-017302 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,056 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 1,200 shares sold ranging from $308.91 to $309.88 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 01, 2019 Filed May 3, 2019 21:18 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 5,000 | $51.17 | $255,850.00 |
DisclosureSEC source: 0001127602-19-017302 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:28 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-19-014722 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:28 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,000 | $314.45 | $314,450.00 |
DisclosureSEC source: 0001127602-19-014722 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,256 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:28 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-19-014722 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:57 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-19-009963 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:57 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,000 | $313.93 | $313,930.00 |
DisclosureSEC source: 0001127602-19-009963 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,256 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:57 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-19-009963 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:45 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-19-004108 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:45 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,000 | $280.11 | $280,110.00 |
DisclosureSEC source: 0001127602-19-004108 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,256 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:45 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-19-004108 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:05 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-19-001365 · form4.xml · derivative · entry 4 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:05 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,000 | $294.71 | $294,710.00 |
DisclosureSEC source: 0001127602-19-001365 · form4.xml · nonDerivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,256 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:05 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-19-001365 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 27, 2018 Filed Jan 4, 2019 22:05 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-001365 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,256 Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-18-035250 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,345 | $343.57 | $462,101.65 |
DisclosureSEC source: 0001127602-18-035250 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,756 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:03 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-18-035250 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 21:01 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-18-031989 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 21:01 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,346 | $311.86 | $419,763.56 |
DisclosureSEC source: 0001127602-18-031989 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,101 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 21:01 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-18-031989 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-18-029367 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,346 | $369.15 | $496,875.90 |
DisclosureSEC source: 0001127602-18-029367 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,447 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-18-029367 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 21:45 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-18-027367 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 21:45 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,346 | $345.14 | $464,558.44 |
DisclosureSEC source: 0001127602-18-027367 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,793 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 21:45 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-18-027367 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| July 23, 2018 Filed Jul 24, 2018 23:21 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 500 | $311.15 | $155,575.00 |
DisclosureSEC source: 0001127602-18-023808 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,139 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 21, 2018 Filed Jun 22, 2018 23:12 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 500 | $288.45 | $144,225.00 |
DisclosureSEC source: 0001127602-18-021798 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,639 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 21:15 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001384101-18-000042 · wf-form4_152840610588973.xml · derivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| May 23, 2018 Filed May 24, 2018 23:18 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 1,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-018874 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,139 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 22, 2018 Filed May 24, 2018 23:18 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 922 | $270.80 | $249,677.60 |
DisclosureSEC source: 0001127602-18-018874 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,666 Read SEC document |
| May 21, 2018 Filed May 22, 2018 21:25 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 500 | $271.00 | $135,500.00 |
DisclosureSEC source: 0001127602-18-018447 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,588 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| May 02, 2018 Filed May 4, 2018 20:17 UTC | FATE THERAPEUTICS INC FATE · Entity 5968 | GrantStock Option (right to buy) · Derivative | 16,000 | Not disclosed Strike: $9.78 | Not disclosed |
DisclosureSEC source: 0001209191-18-028101 · doc4.xml · derivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2028-05-02 F2 · price: Not applicable. F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 00:06 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 250 | $231.25 | $57,812.50 |
DisclosureSEC source: 0001127602-18-009773 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,088 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 01:36 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-18-003053 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 01:36 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,250 | $244.18 | $305,225.00 |
DisclosureSEC source: 0001127602-18-003053 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,338 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 01:36 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-18-003053 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 01:36 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-18-000283 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 01:36 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,250 | $217.38 | $271,725.00 |
DisclosureSEC source: 0001127602-18-000283 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,588 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 01:36 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-18-000283 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:50 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-17-033976 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:50 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 1,250 | $226.55 | $283,187.50 |
DisclosureSEC source: 0001127602-17-033976 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,838 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:50 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-17-033976 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| June 07, 2017 Filed Jun 7, 2017 21:24 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001384101-17-000042 · wf-form4_149687065055546.xml · derivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| May 30, 2017 Filed Jun 2, 2017 00:33 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 2,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020123 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,088 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 18, 2017 Filed May 23, 2017 00:14 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 1,141 | $175.89 | $200,690.49 |
DisclosureSEC source: 0001127602-17-019065 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,783 Read SEC document |
| May 02, 2017 Filed May 4, 2017 16:00 UTC | FATE THERAPEUTICS INC FATE · Entity 5968 | GrantStock Option (right to buy) · Derivative | 25,000 | Not disclosed Strike: $4.73 | Not disclosed |
DisclosureSEC source: 0001209191-17-029931 · doc4.xml · derivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-05-01 F2 · price: Not applicable. F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 22:56 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 300 | $174.29 | $52,287.00 |
DisclosureSEC source: 0001127602-16-062998 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,924 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.